Labcorp Holdings Inc. (NYSE: LH) reported third-quarter 2026 revenue of $3.81 billion, up 6.9% from $3.56 billion a year earlier. Net earnings attributable to Labcorp were $262.8 million, while diluted earnings per share were $3.22, compared with $3.12 in the prior-year quarter.
The company raised its full-year 2026 enterprise revenue growth outlook to 5.9% to 6.7% and its adjusted EPS guidance to $18.30 to $18.70.
- Diagnostics Laboratories revenue increased 6.5% to $2.95 billion.
- Biopharma Laboratory Services revenue increased 8.5% to $866.7 million.
- Labcorp invested $255.5 million in acquisitions and paid $58.2 million in dividends during the quarter.
- The company announced or closed four transactions, including the acquisition of MLM Medical Labs and agreements involving BioReference Health, Myriad Genetics and Millennium Health.
- Labcorp received FDA approval for PGDx elio® tissue complete CDx as a companion diagnostic for advanced melanoma.
$LH Insider Trading Activity
$LH insiders have traded $LH stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $LH stock by insiders over the last 6 months:
- ADAM H SCHECHTER (President & CEO) has made 0 purchases and 2 sales selling 10,572 shares for an estimated $2,998,121.
- KERRII B ANDERSON sold 3,000 shares for an estimated $954,060
- PETER J WILKINSON (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,420 shares for an estimated $439,107.
- AMY B. SUMMY (EVP, Chief Marketing Officer) sold 924 shares for an estimated $283,427
- KATHRYN W KYLE (EVP, Chief Legal Officer) has made 0 purchases and 2 sales selling 854 shares for an estimated $227,413.
- BRYAN T VAUGHN (EVP and President, Diagnostics) sold 234 shares for an estimated $66,968
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LH Hedge Fund Activity
We have seen 454 institutional investors add shares of $LH stock to their portfolio, and 445 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 1,268,384 shares (+inf%) to their portfolio in Q2 2026, for an estimated $355,147,520
- BOSTON PARTNERS added 682,894 shares (+28.8%) to their portfolio in Q2 2026, for an estimated $191,210,320
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 639,261 shares (+inf%) to their portfolio in Q2 2026, for an estimated $178,993,080
- FMR LLC added 616,459 shares (+47.8%) to their portfolio in Q2 2026, for an estimated $172,608,520
- VICTORY CAPITAL MANAGEMENT INC removed 519,252 shares (-9.7%) from their portfolio in Q2 2026, for an estimated $145,390,560
- ALLIANCEBERNSTEIN L.P. removed 459,043 shares (-52.3%) from their portfolio in Q2 2026, for an estimated $128,532,040
- DEKABANK DEUTSCHE GIROZENTRALE added 456,537 shares (+inf%) to their portfolio in Q3 2026, for an estimated $140,663,615
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$LH Congressional Stock Trading
Members of Congress have traded $LH stock 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $LH stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 4 times. They made 0 purchases and 4 sales worth up to $295,000 on 08/25, 08/07, 08/06, 08/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
